Speakers

William (Bill) Hausdorff has worked in the development, testing, implementation and evaluation of a variety of pediatric vaccines for over 25 years.  He currently is an independent consultant, based in Brussels Belgium.

He most recently worked for 12 years with GlaxoSmithKline Vaccines, based in Wavre, Belgium, serving as Vice President for Scientific Affairs & Public Health, as Vaccine Development Leader for Pneumococcal Vaccines and as Director of Epidemiology and Scientific Strategy. 

Prior to that he spent 8 years at Wyeth Vaccines in Rochester, New York in the Scientific Affairs and Research Strategy group.  He is co-holds patents for the design of the 13-valent pneumococcal conjugate vaccine, receiving no royalties as is industry practice.

He previously served as a Technical Advisor with the US Centers for Disease Control and Prevention, based at the US Agency for International Development in Washington DC and Cairo, Egypt.  There he worked to expedite introduction of new vaccines into developing country immunization programs.

His academic background includes a PhD in Biology from Johns Hopkins University/the U.S. National Institutes of Health, and a post-doctoral fellowship in molecular pharmacology at Duke University.  He is the author of numerous scientific articles and book chapters, including extensive publications on the epidemiology of S. pneumoniae disease and the impact of conjugate vaccination.